ArticleBlood advances2021

Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs.

Manjola Balliu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.